| Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease (NCT07620405) | Minghui Pharmaceutical (Hangzhou) Ltd | 2027-07-01 |
| Treatment of Chronic Thyroid Eye Disease With MHB018A (NCT07622121) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-12-01 |
| Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study (NCT07622108) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-12-01 |
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo (NCT07682506) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-08-04 |
| A Study of MHB009C in Patients With Advanced Solid Tumors (NCT07326488) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-03-17 |
| A Study of MHB048C in Patients With Advanced Solid Tumors (NCT07192120) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-01-16 |
| Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease (NCT07262476) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-01-09 |
| A Study of MHB042C in Patients With Advanced Solid Tumors (NCT07192107) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-11-27 |
| A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors (NCT07130383) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-09-30 |
| A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors (NCT07126665) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-09-18 |
| MHB018A Treatment in Patients With Active Thyroid Eye Disease (NCT06989918) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-07-22 |
| A Study of MHB046C Injection in Patients With Advanced Solid Tumors (NCT06985355) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-07-17 |
| A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer (NCT07229599) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-05-09 |
| A Study of MHB118C Injection in Patients With Advanced Solid Tumors (NCT07045454) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-03-31 |
| A Study of MHB039A for Advanced Solid Tumor (NCT06345482) | Minghui Pharmaceutical (Hangzhou) Ltd | 2024-04-16 |
| Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo (NCT07181187) | Minghui Pharmaceutical (Hangzhou) Ltd | 2024-03-26 |
| A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis (NCT07185282) | Minghui Pharmaceutical (Hangzhou) Ltd | 2023-06-10 |
| A Study of MHB036C for Advanced Solid Tumor (NCT06373406) | Minghui Pharmaceutical (Hangzhou) Ltd | 2023-05-26 |
| MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis (NCT07182864) | Minghui Pharmaceutical (Hangzhou) Ltd | 2022-01-06 |